that probably doesnít quite fit in there but came out of a workshop we had a year or so
ago, trying to look at directions, is that itís important to admit that our knowledge is
limited, it could be wrong. For example, as in the aspirin trial, it may not work at all.
If we should be in a situation where we donít take advantage of that study to learn more
about the disease itís almost criminal not to add another 15% or 20% expense to the
study to be certain that if it doesnít work we can learn more about the disease.
Go to Part II of this lecture
||Go to Comment Form